SoluBest has conducted extensive testing of its platform through its Proof-of-Concept compounds:
SoluFeno: A reformulation of Fenofibrate which has been shown to be bioequivalent to marketed nanoparticle product Tricor 145 –currently an over billion dollar drug in the US market.
SoluDrug 2: The insoluble anti-oxidant Resveratrol, its solumerized form has been clinically proven to have at least 5x better bioavailability
SoluDrug 3: Albendazole, this anti-parasitic agent has been shown in pre-clinical trials to have significantly better bioavailability when solumerized, leading to increased efficacy
